Do patients think cannabis causes schizophrenia? - A qualitative study on the causal beliefs of cannabis using patients with schizophrenia

Harm Reduction Journal

Volumn 7, Issue , 2010, Pages

  Buadze, Anna ^a   Stohler, Rudolf ^a   Schulze, Beate ^b,d   Schaub, Michael ^c   Liebrenz, Michael ^a  

^a UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c Institut fur Sucht und Gesundheitsforschung Zurich   (Switzerland)

^d UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; PSYCHEDELIC AGENT;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; DISEASE EXACERBATION; FEMALE; HUMAN; MALE; PARANOID SCHIZOPHRENIA; PATIENT ATTITUDE; PERCEPTION; POSITIVE SYNDROME; QUALITATIVE RESEARCH; SCHIZOPHRENIA; SUBSTANCE ABUSE;

EID: 77957131515     PISSN: None     EISSN: 14777517     Source Type: Journal    
DOI: 10.1186/1477-7517-7-22     Document Type: Article

References (32)

1. Hall W. Is cannabis use psychotogenic?. Lancet 2006, 367:193-195. 10.1016/S0140-6736(06)68012-4, 16427475.
2. Macleod J, Davey Smith G, Hickman M. Does cannabis use cause schizophrenia?. Lancet 2006, 367:1055. 10.1016/S0140-6736(06)68468-7, 16581402.
3. Zammit S, Moore TH, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G. Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry 2008, 193:357-363. 10.1192/bjp.bp.107.046375, 18978312.
4. Andreasson S, Allebeck P, Engstrom A, Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 1987, 2:1483-1486. 10.1016/S0140-6736(87)92620-1, 2892048.
5. Macleod J, Oakes R, Copello A, Crome I, Egger M, Hickman M, Oppenkowski T, Stokes-Lampard H, Davey Smith G. Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet 2004, 363:1579-1588. 10.1016/S0140-6736(04)16200-4, 15145631.
6. Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007, 370:319-328. 10.1016/S0140-6736(07)61162-3, 17662880.
7. Kuper A, Reeves S, Levinson W. An introduction to reading and appraising qualitative research. BMJ (Clinical research ed 2008, 337:a288. 10.1136/bmj.a288, 18687727.
8. Lawton J, Peel E, Parry O, Douglas M. Patients' perceptions and experiences of taking oral glucose-lowering agents: a longitudinal qualitative study. Diabet Med 2008, 25:491-495. 10.1111/j.1464-5491.2008.02400.x, 18294222.
9. Benson J, Britten N. Patients' decisions about whether or not to take antihypertensive drugs: qualitative study. BMJ (Clinical research ed 2002, 325:873. 10.1136/bmj.325.7369.873, 129637, 12386041.
10. Farber SJ, Egnew TR, Herman-Bertsch JL, Taylor TR, Guldin GE. Issues in end-of-life care: patient, caregiver, and clinician perceptions. Journal of palliative medicine 2003, 6:19-31. 10.1089/10966210360510082, 12710572.
11. Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. The American journal of psychiatry 1991, 148:224-230.
12. Schaub M, Fanghaenel K, Stohler R. Reasons for cannabis use: patients with schizophrenia versus matched healthy controls. The Australian and New Zealand journal of psychiatry 2008, 42:1060-1065. 10.1080/00048670802512016, 19016094.
13. Schofield D, Tennant C, Nash L, Degenhardt L, Cornish A, Hobbs C, Brennan G. Reasons for cannabis use in psychosis. The Australian and New Zealand journal of psychiatry 2006, 40:570-574.
14. Addington J, Duchak V. Reasons for substance use in schizophrenia. Acta Psychiatr Scand 1997, 96:329-333. 10.1111/j.1600-0447.1997.tb09925.x, 9395149.
15. Goswami S, Mattoo SK, Basu D, Singh G. Substance-abusing schizophrenics: do they self-medicate?. Am J Addict 2004, 13:139-150. 10.1080/10550490490435795, 15204665.
16. Faller H. [Subjective illness theories: determinants or epiphenomena of coping with illness? A comparison of methods in patients with bronchial cancer]. Zeitschrift fur Psychosomatische Medizin und Psychoanalyse 1993, 39:356-374.
17. Patton MQ. Qualitative evaluation and research methods. Newbury Park, CA:Sage 1990,
18. Pope C, Mays N. Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research. BMJ (Clinical research ed 1995, 311:42-45. 2550091, 7613329.
19. Glaser BJ, Strauss AL. Grounded Theory: Strategien qualitativer Forschung (Grounded theory: Strategies for qualitative research) 2008, Bern: Huber, 2.
20. Faller H, Frommer J. Qualitative Psychotherapieforschung. Grundlagen und Methoden. Heidelberg: Asanger 1994,
21. Glaser BJ, Strauss AL. The discovery of grounded theory: Strategies for Qualitative Research. Chicago, IL: Aldine De Gruyther 1967,
22. Mayring P. Qualitative Inhaltsanalyse (Qualitative Content Analysis). Qualitative Forschung Ein Handbuch (Qualitative Research: A Handbook) 2005, 468-475. Reinbeck bei Hamburg: Rowohlts Taschenbuch Verlag, Flick U, Kardorff E, Steinke I, 4.
23. Angermeyer MC, Klusmann D. The causes of functional psychoses as seen by patients and their relatives. I. The patients' point of view. European archives of psychiatry and neurological sciences 1988, 238:47-54. 10.1007/BF00381080, 3215220.
24. Holzinger A, Loffler W, Muller P, Priebe S, Angermeyer MC. [Causal beliefs of schizophrenic patients]. Psychotherapie, Psychosomatik, medizinische Psychologie 2001, 51:328-333. 10.1055/s-2001-15995, 11536075.
25. van Os J, Rutten BP, Poulton R. Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophrenia bulletin 2008, 34:1066-1082. 10.1093/schbul/sbn117, 2632485, 18791076.
26. Dekker N, Linszen DH, De Haan L. Reasons for Cannabis Use and Effects of Cannabis Use as Reported by Patients with Psychotic Disorders. Psychopathology 2009, 42:350-360. 10.1159/000236906, 19752588.
27. McLaren J, Swift W, Dillon P, Allsop S. Cannabis potency and contamination: a review of the literature. Addiction (Abingdon, England) 2008, 103:1100-1109.
28. Orcutt JD. Social determinants of alcohol and marijuana effects: a systematic theory. Int J Addict 1975, 10:1021-1033.
29. Schulze B. Stigma and mental health professionals: a review of the evidence on an intricate relationship. Int Rev Psychiatry 2007, 19:137-155. 10.1080/09540260701278929, 17464792.
30. Schulze B, Angermeyer MC. Subjective experiences of stigma. A focus group study of schizophrenic patients, their relatives and mental health professionals. Soc Sci Med 2003, 56:299-312. 10.1016/S0277-9536(02)00028-X, 12473315.
31. van Zelst C. Stigmatization as an environmental risk in schizophrenia: a user perspective. Schizophrenia bulletin 2009, 35:293-296. 10.1093/schbul/sbn184, 2659317, 19155343.
32. Echebarria Echabe A, Sanjuan Guillen C, Agustin Ozamiz J. Representations of health, illness and medicines: coping strategies and health-promoting behaviour. Br J Clin Psychol 1992, 31(Pt 3):339-349.